Barclays analyst Benjamin Budish raised the firm’s price target on CME Group to $230 from $215 and keeps an Overweight rating on the shares. The company’s’ earnings beat Q2 estimates and management struck an optimistic tone regarding the growth outlook for the business, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CME: